Conventional transcatheter arterial chemoembolization: Clinical Trials

1 trial of Conventional transcatheter arterial chemoembolization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Conventional transcatheter arterial chemoembolization: new trials by email Literature Review of Conventional transcatheter arterial chemoembolization trials Research Report on Conventional transcatheter arterial chemoembolization

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
Yttrium [90Y] Microsphere Injection, Conventional transcatheter arterial chemoembolization, Camrelizumab - HCC
Phase 2RecruitingGrandPharma (China) Co., Ltd.1202025-08-222026-01-12

Sponsors

GrandPharma (China) Co., Ltd. (1)

Countries

China (1)

Top investigators

Zhiping Yan, MD (1)